Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» postpartum depression
postpartum depression
Here's Why Sage Therapeutics Gained 48.9% in January
Motley Fool
Sun, 02/10/19 - 11:04 pm
SAGE Therapeutics
SAGE-217
postpartum depression
clinical trials
Sage shrugs off potential competition in postpartum depression, asserts plan to remain independent
Endpoints
Tue, 01/8/19 - 09:28 am
SAGE Therapeutics
postpartum depression
SAGE-217
Sage Therapeutics pill improves postpartum depression in pivotal clinical trial
Stat
Mon, 01/7/19 - 10:12 am
SAGE Therapeutics
clinical trials
postpartum depression
SAGE-217
PDUFA Date for Postpartum Depression Drug Delayed Three months
CP Wire
Tue, 11/20/18 - 09:42 am
FDA
SAGE Therapeutics
postpartum depression
Zulresso
PDUFA Date for Postpartum Depression Drug Delayed Three months
Tue, 11/20/18 - 09:23 am
Zulresso
postpartum depression
SAGE Therapeutics
Sage depression drug to cost between $20K and $35K, if approved
Biopharma Dive
Wed, 11/7/18 - 07:12 pm
SAGE Therapeutics
Zulresso
postpartum depression
FDA
drug pricing
With FDA Panel’s Nod, First Postpartum Depression Drug Nears Approval
Xconomy
Fri, 11/2/18 - 07:54 pm
FDA
advisory panels
SAGE Therapeutics
postpartum depression
brexanolone
FDA reviewers: REMS could allay safety concerns for Sage's brexanolone
BioCentury
Wed, 10/31/18 - 06:47 pm
FDA
SAGE Therapeutics
postpartum depression
SAGE-547
brexanolone
REMS
Sage to Expedite Development of SAGE-217 in Major Depressive Disorder and Postpartum Depression
CP Wire
Tue, 06/12/18 - 10:00 am
SAGE Therapeutics
FDA
breakthrough status
SAGE-217
major depressive disorder
postpartum depression
Sage to Expedite Development of SAGE-217 in Major Depressive Disorder and Postpartum Depression
Tue, 06/12/18 - 09:42 am
SAGE Therapeutics
SAGE-217
major depressive disorder
postpartum depression
Sage Therapeutics wins priority review for intravenous postpartum depression drug
Drug Delivery Business News
Wed, 05/30/18 - 10:08 am
SAGE Therapeutics
FDA
brexanolone
postpartum depression
Sage Postpartum Depression Drug Heads to FDA Review
Xconomy
Mon, 04/23/18 - 09:35 am
SAGE Therapeutics
FDA
brexanolone
postpartum depression
3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 11/12/17 - 10:32 am
biotech
Nektar
earnings
SAGE Therapeutics
brexanolone
postpartum depression
Valeant Pharmaceuticals
Sage Bounces Back, Eyes FDA Filing for Postpartum Drug
Xconomy
Thu, 11/9/17 - 10:04 am
SAGE Therapeutics
postpartum depression
brexanolone
FDA
clinical trials
The FDA just signed off on a Formula 1 pivotal track for Sage’s postpartum depression drug
Endpoints
Tue, 12/6/16 - 09:46 am
FDA
SAGE Therapeutics
postpartum depression
SAGE-547
Sage Therapeutics shares surge 45% on positive trial of postpartum depression drug
Marketwatch
Tue, 07/12/16 - 11:15 am
SAGE Therapeutics
SAGE-547
postpartum depression
Sage gets a peek at success treating postpartum depression, and its shares soar
Fierce Biotech
Tue, 06/9/15 - 09:38 am
SAGE Therapeutics
postpartum depression
SAGE-547
Pages
« first
‹ previous
1
2